B. Shankar

Synergy Testing between Sulbactam and Meropenem/ Colistin in MDR Acinetobacter baumannii-calcoaceticus Complex Isolated from VentilatorAssociated Pneumonia

J. Peter, B. Veeraraghavan, S. An, 2016 .

Genome sequencing and molecular characterisation of XDR Acinetobacter baumannii reveal complexities in resistance: Novel combination of sulbactam–durlobactam holds promise for therapeutic intervention

Sudha Ramaiah, A. Anbarasu, B. Veeraraghavan, 2021, Journal of cellular biochemistry.

Genome sequencing and molecular characterisation of XDR Acinetobacter baumannii reveal complexities in resistance: Novel combination of Sulbactam-Durlobactam holds promise for therapeutic intervention

Sudha Ramaiah, A. Anbarasu, B. Veeraraghavan, 2021, bioRxiv.

MLST based serotype prediction for the accurate identification of non typhoidal Salmonella serovars

Karthik Gunasekaran, B. Veeraraghavan, J. Jacob, 2020, Molecular Biology Reports.

Will ceftazidime/avibactam plus aztreonam be effective for NDM and OXA-48-Like producing organisms: Lessons learnt from In vitro study

B. George, B. Veeraraghavan, Y. Bakthavatchalam, 2019, Indian journal of medical microbiology.

Draft genome sequence of blaTEM-1-mediated cephalosporin-resistant Salmonella enterica serovar Typhi from bloodstream infection.

B. Veeraraghavan, D. M. Muthuirulandi Sethuvel, N. D. Devanga Ragupathi, 2016, Journal of global antimicrobial resistance.

In vitro efficacy and in silico analysis of cefixime–ofloxacin combination for Salmonella Typhi from bloodstream infection

C. Doss, B. Veeraraghavan, Y. Bakthavatchalam, 2017, Journal of applied microbiology.

KPC-2 producing ST101 Klebsiella pneumoniae from bloodstream infection in India.

B. Veeraraghavan, C. Shankar, B. Shankar, 2018, Journal of medical microbiology.

Colistin resistance in Acinetobacter baumannii is driven by multiple genomic traits: Evaluating the role of ISAba1-driven eptA overexpression among Indian isolates

K. Kaye, Karthik Gunasekaran, I. Biswas, 2021, bioRxiv.

Enhanced bacterial killing with a combination of sulbactam/minocycline against dual carbapenemase-producing Acinetobacter baumannii

B. Veeraraghavan, Y. Bakthavatchalam, S. Vijayakumar, 2023, European Journal of Clinical Microbiology & Infectious Diseases.